Session

Liver & biliary (Posters)

INTERNATIONAL FRENCH-SPEAKING MULTICENTRE PRACTICE SURVEY ON HEPATIC HYDROTHORAX (HH) : RESULTS OF THE "HEP HEP" STUDY AMONG 529 HEPATOGASTROENTEROLOGIST (HG) OR PNEUMOLOGIST (PN) RESPONDENTS
INTERNATIONAL FRENCH-SPEAKING MULTICENTRE PRACTICE SURVEY ON HEPATIC HYDROTHORAX (HH) : RESULTS OF THE "HEP HEP" STUDY AMONG 529 HEPATOGASTROENTEROLOGIST (HG) OR PNEUMOLOGIST (PN) RESPONDENTS

Liver & biliary (Posters)  et al.

NEW TOOLS FOR PREDICTING SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
NEW TOOLS FOR PREDICTING SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB

Liver & biliary (Posters)  et al.

PROCALCITONIN, NONALCOHOLIC FATTY LIVER DISEASE AND GUT MICROBIOME
PROCALCITONIN, NONALCOHOLIC FATTY LIVER DISEASE AND GUT MICROBIOME

Liver & biliary (Posters)  et al.

CAN SERUM FERRITIN PREDICT 30 DAYS MORTALITY IN PATIENTS WITH DECOMPENSATED CIRRHOSIS?
CAN SERUM FERRITIN PREDICT 30 DAYS MORTALITY IN PATIENTS WITH DECOMPENSATED CIRRHOSIS?

Liver & biliary (Posters)  et al.

THE SHIFT IN PREVALENCE, INCIDENCE, AND MORTALITY RATES OF VIRAL HEPATITIS TYPES A, B, C AND D IN BRAZILIAN CITIZENS BETWEEN 1999 AND 2019
THE SHIFT IN PREVALENCE, INCIDENCE, AND MORTALITY RATES OF VIRAL HEPATITIS TYPES A, B, C AND D IN BRAZILIAN CITIZENS BETWEEN 1999 AND 2019

Liver & biliary (Posters)  et al.

NOVEL PATHOGENIC ALG8 VARIANTS AND EVIDENCE FOR SOMATIC LOSS OF HETEROZYGOSITY IN 199 AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE PATIENTS
NOVEL PATHOGENIC ALG8 VARIANTS AND EVIDENCE FOR SOMATIC LOSS OF HETEROZYGOSITY IN 199 AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE PATIENTS

Liver & biliary (Posters)  et al.

DISTINCT EFFECTS OF IGFBP2 ON VIABILITY OF HEPATOMA CELLS – A MATTER OF DOSE
DISTINCT EFFECTS OF IGFBP2 ON VIABILITY OF HEPATOMA CELLS – A MATTER OF DOSE

Liver & biliary (Posters)  et al.

PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN POST VIRAL CIRRHOSIS: PERFORMANCE OF THE NEUTROPHIL-TO-LYMPHOCYTE RATIO AND THE PLATELET-TO-LYMPHOCYTE RATIO
PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN POST VIRAL CIRRHOSIS: PERFORMANCE OF THE NEUTROPHIL-TO-LYMPHOCYTE RATIO AND THE PLATELET-TO-LYMPHOCYTE RATIO

Liver & biliary (Posters)  et al.

ELEVATED LIVER AMINOTRANSFERASES LEVEL AND COVID-19 PROGNOSIS
ELEVATED LIVER AMINOTRANSFERASES LEVEL AND COVID-19 PROGNOSIS

Liver & biliary (Posters)  et al.

PROTEASE-DEPENDENT LOSS OF INTESTINAL EPITHELIAL INTEGRITY IN SPONTANEOUS BACTERIAL PERITONITIS
PROTEASE-DEPENDENT LOSS OF INTESTINAL EPITHELIAL INTEGRITY IN SPONTANEOUS BACTERIAL PERITONITIS

Liver & biliary (Posters)  et al.

THE ANTIRETROVIRAL DRUG RILPIVIRINE DIMINISHES IP-10/CXCL10 EXPRESSION: RELEVANCE IN THE CONTEXT OF LIVER DISEASE
THE ANTIRETROVIRAL DRUG RILPIVIRINE DIMINISHES IP-10/CXCL10 EXPRESSION: RELEVANCE IN THE CONTEXT OF LIVER DISEASE

Liver & biliary (Posters)  et al.

GENOME-WIDE CRISPR/CAS9 KNOCKOUT SCREENING FOR THE IDENTIFICATION OF CRITICAL RESISTANCE DRIVERS IN DIMETHYL FUMARATE TREATED TUMORS
GENOME-WIDE CRISPR/CAS9 KNOCKOUT SCREENING FOR THE IDENTIFICATION OF CRITICAL RESISTANCE DRIVERS IN DIMETHYL FUMARATE TREATED TUMORS

Liver & biliary (Posters)  et al.

NURSE INTERVENTION OPTIMIZES THE CARE OF PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDER SECOND/THIRD-LINE TREATMENTS
NURSE INTERVENTION OPTIMIZES THE CARE OF PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDER SECOND/THIRD-LINE TREATMENTS

Liver & biliary (Posters)  et al.

OUTCOMES OF PATIENTS WITH ALCOHOLIC LIVER DISEASE AFFECTED WITH THE METABOLIC SYNDROME
OUTCOMES OF PATIENTS WITH ALCOHOLIC LIVER DISEASE AFFECTED WITH THE METABOLIC SYNDROME

Liver & biliary (Posters)  et al.

FAILURE OF ULTRASOUND-BASED SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN PATIENTS AT RISK IS FREQUENT AND ASSOCIATED WITH DETECTION AT LATER TUMOR STAGES, NON-CURATIVE TREATMENT OPTIONS AND REDUCED SURVIVAL. RESULTS FROM A GERMAN MULTI-CENTER RETROSPECTIV
FAILURE OF ULTRASOUND-BASED SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN PATIENTS AT RISK IS FREQUENT AND ASSOCIATED WITH DETECTION AT LATER TUMOR STAGES, NON-CURATIVE TREATMENT OPTIONS AND REDUCED SURVIVAL. RESULTS FROM A GERMAN MULTI-CENTER RETROSPECTIV

Liver & biliary (Posters)  et al.

ELEVATED SERUM LEVELS OF METHYLGLYOXAL ARE ASSOCIATED WITH AN IMPAIRED LIVER FUNCTION AND LIVER-RELATED COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS
ELEVATED SERUM LEVELS OF METHYLGLYOXAL ARE ASSOCIATED WITH AN IMPAIRED LIVER FUNCTION AND LIVER-RELATED COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS

Liver & biliary (Posters)  et al.

THE INTERRELATION BETWEEN OVERT OR SUBCLINICAL HYPOTHYROIDISM AND NON-ALCOHOLIC FATTY LIVER DISEASE
THE INTERRELATION BETWEEN OVERT OR SUBCLINICAL HYPOTHYROIDISM AND NON-ALCOHOLIC FATTY LIVER DISEASE

Liver & biliary (Posters)  et al.

PREDICTORS OF NON-RESPONSE TO CORTICOSTEROIDS IN SEVERE ACUTE AUTOIMMUNE HEPATITIS
PREDICTORS OF NON-RESPONSE TO CORTICOSTEROIDS IN SEVERE ACUTE AUTOIMMUNE HEPATITIS

Liver & biliary (Posters)  et al.

RESISTANCE OF FIRST-LINE EMPIRIC ANTIMICROBIAL THERAPY IN PATIENTS WITH ACUTE CHOLANGITIS ACCORDING TO TOKYO GUIDELINES 2018
RESISTANCE OF FIRST-LINE EMPIRIC ANTIMICROBIAL THERAPY IN PATIENTS WITH ACUTE CHOLANGITIS ACCORDING TO TOKYO GUIDELINES 2018

Liver & biliary (Posters)  et al.

HIGH INCIDENCE OF HEPATITIS B CORE ANTIBODY POSITIVITY IN METABOLIC-ASSOCIATED FATTY LIVER DISEASE-RELATED CIRRHOSIS
HIGH INCIDENCE OF HEPATITIS B CORE ANTIBODY POSITIVITY IN METABOLIC-ASSOCIATED FATTY LIVER DISEASE-RELATED CIRRHOSIS

Liver & biliary (Posters)  et al.

Item 181 - 200 / 270
1 2 3 4 5 6 7 8 9
10
11 12 13 14